Nanotechnology-Driven (18)F-FDG Imaging to Understand the Change in Insulin Sensitivity: Current Evidence, Methodological Gaps, and Translational Challenges

Authors: Yao, Shuai; Zhao, Jingmin

Source journal: International journal of nanomedicine (2026-01-01)

DOI: 10.2147/IJN.S635935

Abstract

Insulin resistance is an important metabolic derangement contributing to the pathogenesis of type 2 diabetes, obesity, metabolic syndrome, and other chronic diseases, underlining the requirement for techniques that enable in vivo analysis of tissue-specific glucose metabolism. (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) allows the noninvasive evaluation of glucose uptake and metabolism; however, standard (18)F-FDG PET is dependent on systemic glucose and insulin levels, tracer kinetics, tissue-specific characteristics, and application of kinetic modeling for quantification. Therefore, nanotechnology was considered a promising technique to manipulate tracer delivery, biodistribution, targeting, and multimodal imaging abilities. Yet, there is limited experimental data in favor of using nano-FDG as a quantitative biomarker of insulin resistance. The majority of relevant studies originate from the oncological, inflammatory, nanoparticle design, and multimodal PET/CT (Positron Emission Tomography-Computed Tomography scan) and PET/MRI (Positron Emission Tomography/Magnetic Resonance Imaging) fields, but not from validations against metabolic gold standards such as the hyperinsulinemic-euglycemic clamp method. The present review evaluates the literature on the use of (18)F-FDG-based nanotechnology platforms, glucose-labeled nanoparticles, radioactively labeled nanomaterials, and standard (18)F-FDG PET for assessment of nanoparticle-based therapies in terms of direct and indirect evidence.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.